PDB-101: Molecule of the Month: PROTACs and Molecular Glue Degraders
pdb101.rcsb.org · 781 words · saved by 1 readers
Therapeutic molecules that target proteins for degradation
In our cells, proteins are constantly being synthesized in order to carry out the multitude of tasks needed to maintain life. When proteins are damaged, misfolded, or no longer needed, they are degraded and their amino acids recycled. Protein degradation is largely carried out by the ubiquitin-proteasome system, in which proteins are tagged for destruction with a covalently attached chain of ubiquitin molecules. The proteasome recognizes the ubiquitin chain and breaks down the tagged protein into short peptide fragments. Protein ubiquitination is a carefully regulated multistep process.…
saved by
related reading
- Eliglustat - Wikipediaen.wikipedia.org
- A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher diseasepmc.ncbi.nlm.nih.gov
- PDB101: Molecule of the Month: Rubiscopdb101.rcsb.org
- Technologies to measure and modulate protein subcellular localizationnature.com
- TGP, an extremely stable, non-aggregating fluorescent protein created by structure-guided surface engineeringpmc.ncbi.nlm.nih.gov
- Glycosyltransferase Structure and Functionlink.springer.com
- Matrix metalloproteinaseen.wikipedia.org
- Phosphoglucomutaseen.wikipedia.org
- Lysosome-targeting chimaeras for degradation of extracellular proteins | Naturenature.com
- Development of a targeted BioPROTAC degrader selective for misfolded SOD1nature.com
- Protein degradation reaches further outnature.com
- The novel mechanism of lenalidomide activity - PMCncbi.nlm.nih.gov